Inflammation: FDA reporting patterns
50,654 FDA FAERS reports mention Inflammation. 37,832 reports have a serious outcome flag.
Medicines named as suspect
- Adalimumab: 9,565 reports
- Etanercept: 6,223 reports
- Methotrexate: 5,421 reports
- Infliximab: 4,355 reports
- Rituximab: 4,027 reports
- Secukinumab: 3,851 reports
- Tocilizumab: 3,650 reports
- Abatacept: 3,544 reports
- Tofacitinib: 3,430 reports
- Leflunomide: 3,390 reports
- Hydroxychloroquine: 3,120 reports
- Prednisone: 2,997 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.